Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV — Stella

Recruiting

Back to Obesity trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Ireland

Mater Misericordiae University Hospital, Dublin

Key details

Sponsor

University College Dublin

Collaborators

University of Copenhagen, Rush University Medical Center

Enrollment target

~80 participants

Started

June 2022

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov